Crossmark

Neoadjuvanz mit Nivolumab/Chemtoherapie bei NSCLC

Crossref DOI link: https://doi.org/10.1007/s15015-020-2695-5

Published Online: 2020-12-14

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2020-12-01

Version of Record valid from 2020-12-01
More Information

Article History

First Online: 14 December 2020

Free to read: This content has been made available to all.